As a key Medical Advisor for HistoSonics, Jeff Geschwind, MD helps pioneer a non-invasive, image-guided therapy for liver cancer. His clinical expertise is vital in developing this transformative technology that aims to destroy tumors without a single incision, revolutionizing patient care. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/